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Edited by Sandro SonninoAbstract S-Adenosyl-L-homocysteine hydrolase (Sah1p, EC
3.3.1.1.) is a key enzyme of methylation metabolism. It
catabolizes S-adenosyl-L-homocysteine, which is formed after
donation of the activated methyl group of S-adenosyl-L-methi-
onine (AdoMet) to an acceptor, and which acts as strong
competitive inhibitor of all AdoMet-dependent methyltransfe-
rases. Sah1p is an essential enzyme in yeast and one of the most
highly conserved proteins with up to 80% sequence homology
throughout all kingdoms of life. SAH1 expression in yeast is
subject to the general transcriptional control of phospholipid
synthesis. Profound changes in cellular lipid composition upon
depletion of Sah1p support the notion of a tight interaction
between lipid metabolism and Sah1p function.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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S-Adenosyl-L-methionine (AdoMet) serves as the major
methyl group donor for numerous highly speciﬁc methyl-
transferase reactions that involve a large variety of acceptor
molecules, ranging from DNA, RNA and proteins to phos-
pholipids and sterols [1–7]. In yeast and in higher eukaryotes,
the major phospholipid, phosphatidylcholine (PtdCho), is
synthesized de novo by three-step AdoMet-dependent meth-
ylation of phosphatidylethanolamine (PtdEtn). Ergosterol, the
major yeast sterol, diﬀers mainly in its side-chain from cho-
lesterol present in mammals by an additional methyl group
that is introduced by the AdoMet-dependent methyltransfer-
ase, Erg6p.
S-Adenosyl-L-homocysteine (AdoHcy), that is formed after
donation of the activated methyl group of AdoMet to a methyl
acceptor, is a strong competitive inhibitor of all AdoMet-de-* Corresponding author. Fax: +43-316-380-9857.
E-mail address: sepp.kohlwein@uni-graz.at (S.D. Kohlwein).
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syl-L-homocysteine; Sah1p, S-adenosyl-L-homocysteine hydrolase;
PtdCho, phosphatidylcholine; PtdEtn, phosphatidylethanolamine
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adenosyl-L-homocysteine hydrolase (Sah1p) oﬀers a single way
for AdoHcy removal by hydrolysis to adenosine and homo-
cysteine. Since this reaction is reversible, an increase in ho-
mocysteine levels may drive the formation of AdoHcy.
According to its central role in controlling the methylation
potential of the cell, Sah1p is a potential target for drugs of
pharmacological interest, in particular in the context of
methylation dependent viral replication. Clinical application,
however, is limited due to the high cytotoxicity of Sah1p
inhibitors.
In the yeast Saccharomyces cerevisiae, genes involved in lipid
biosynthesis are subject to coordinated transcriptional regula-
tion in response to the availability of lipid precursors, inositol
and choline. These coregulated structural genes contain one or
more copies of an inositol/choline response element, ICRE
(UASINO), in their promoter regions [8], which mediate repres-
sion/de-repression in the presence or absence of lipid precursors,
respectively. In a screening for genes which are regulated at the
transcriptional level by inositol and choline [9], we have iden-
tiﬁed the yeast SAH1 gene, encoding Sah1p. SAH1 is an
essential gene in yeast. Our data suggest thatSAH1 expression is
coordinately regulated with genes involved in phospholipid
biosynthesis. Sah1p depletion led to signiﬁcant changes in lipid
metabolism, resulting in accumulation of triglycerides.2. Materials and methods
2.1. Strains and media
S. cerevisiae wild-type strain W303D (R.Rothstein) was used
throughout this study. Strains MSH-100 (W303D SAH1/sah1::URA3)
and YSH-100 (W303D SAH1/sah1::LEU2) heterozygous for the sah1
null mutation were constructed as described below. Deﬁned yeast
media lacking or containing inositol (80 lM) and choline (1 mM),
respectively, were prepared as described previously [10]. Methionine
was supplemented at concentrations of 0.1 and 1 mM. Escherichia coli
and yeast cells were grown under standard conditions [11].
2.2. Plasmid constructions and gene disruption
Plasmid pBlueScript SK (Stratagene) was used for standard DNA
manipulations. Plasmid p18.2 harboring a 1658 bp EcoRI–XhoI cDNA
insert was isolated in a diﬀerential screening for yeast genes that are
regulated at the transcriptional level by lipid precursors, inositol and
choline [9]. Plasmids p18.2DURA3 and p18.2DLEU2 were constructed
by replacing the HincII–HincII fragment of plasmid p18.2 by URA3 or
LEU2 selectable markers that were isolated from plasmids pJH-U1
and pJH-L3 (provided by J. Hill), cut with HindIII and HindIII/SacI,
respectively, and blunt ended. Disruption of the SAH1 chromosomalation of European Biochemical Societies.
Fig. 1. Scheme of methylation metabolism and the role of Sah1p in lipid biosynthesis.
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W303D with AatII–BglII fragments of plasmids p18.2DURA3 and
p18.2DLEU2, followed by selection of transformants for Uraþ or Leuþ
prototrophy [12]. Deletion of nucleotides 547 through 1042 of the
SAH1 reading frame was conﬁrmed by PCR [11] of whole yeast cell
extracts [13] using SAH1 and marker gene speciﬁc primers. In both
cases, the observed fragment length of the PCR products matched the
predicted sizes for URA3 and LEU2 disruption, in addition to the
fragment of the wild-type allele. The SAH1 reading frame was put
under control of the regulatable GAL1 promoter by inserting the
BamHI–BclI fragment of plasmid p18.2 into the BamHI site of plasmid
pYES2 (Invitrogen). The resulting pYES2-SAH1 vector was trans-
formed into yeast strain YSH-100, yielding strain YSH-120. For
constitutive expression, the SAH1 reading frame was put under control
of the PGK promoter by inserting the BamHI–BclI fragment of plas-
mid p18.2 into the BglII site of vector pMA91 [14]. The resulting
pMA91-SAH1 vector was transformed into strain MSH-100, yielding
strain MSH-120.
2.3. RNA isolation and hybridization
Yeast total RNA was prepared by the hot phenol method [11] from
wild type strain W303D grown to OD600 1 in deﬁned medium with
diﬀerential supplementation of lipid precursors, inositol and choline,
as indicated. Each 7 lg of total RNA was separated on a 1.2% agarose
gel under denaturing conditions and transferred to uncharged nylon
membranes (Qiagen) using a PosiblotTM Pressure Blotter (Stratagene)
in 20xSSC transfer buﬀer (3 M NaCl and 0.3 M Na-citrate, pH 7.0).
After UV-crosslinking (StratalinkerR1800, Stratagene), the membrane
was probed with DIG-labeled SAH1-speciﬁc probe [11]. DIG-labeled
PMA1-speciﬁc probe was used as the internal standard. Signals were
detected using chemiluminiscent detection with CDP-StarR (Roche)
and quantiﬁed by densitometric scanning.
2.4. Preparation of cytosolic extracts
Yeast cells grown to mid-logarithmic phase (OD600 1–2) in deﬁned
medium were harvested by centrifugation and resuspended in breaking
buﬀer (10 mM Tris–HCl and 1 mM PMSF, pH 7.4) [11]. Cells were
disrupted with glass beads in a Braun-Melsungen homogeniser under
CO2-cooling. The homogenate was centrifuged at 5000 g for 10 min
and at 40 000 g for 1 h at 4 C. Protein concentrations were deter-
mined according to Lowry [15].
2.5. Enzyme assay
Sah1p activity was determined in the direction of AdoHcy synthesis
[16]. The standard reaction mixture of 90 ll contained 50 mM Tris–
HCl, pH 8.5, 0.5 mM adenosine, 0.1 lCi of [8-14C]adenosine (59.8
mCi/mmol, Du Pont), 10 mM DL-homocysteine, 33 lM b-mercap-toethanol and 50–100 lg of enzyme preparation. Incubations were
carried out at 30 C. Aliquots were taken during 30 min of incubation,
the reaction was stopped by addition of 10 ll of a 50 % (w/v) solution
of trichloroacetic acid and the samples were kept on ice for 10 min. The
protein precipitate was removed by centrifugation and the supernatant
was stored at )20 C until further use. For product identiﬁcation, 10 ll
reaction aliquots were separated on silica gel TLC plates (silica gel 60
F254, Merck) using as a solvent n-butanol/acetic acid/water, 12:3:5 (v/
v/v). Zones containing AdoHcy were identiﬁed by scanning with a
TLC-linear analyser Tracemaster 20 (Berthold Analytic Instruments),
cut out and radioactivity determined by liquid scintillation counting.
2.6. Lipid analyses
Lipid extracts were prepared by the Folch method [17]. Phospho-
lipids and neutral lipids were determined according to published pro-
cedures [18,19].
2.7. Miscellaneous procedures
DNA manipulation, plasmid transformation into E. coli and its re-
trieval from E. coli were performed following standard procedures [11].
Transformation of S. cerevisiae was carried out using the lithium ac-
etate method [12]. DNA sequencing was performed using the dye-
terminator method [20] on an ABI sequencer. Sequences were edited
and analyzed using the GCG Wisconsin program package [21].
Comparison to nucleic acid sequence databases was performed using
BLAST [22] and sequence alignments were computed using MACAW
[23].3. Results
3.1. Sequence analysis and evolutionary conservation of Sah1p
The SAH1 structural gene was cloned in a screening de-
signed to identify genes that are transcriptionally regulated by
lipid precursors, inositol and choline [8,9]. Sequence analysis
unveiled that the cloned cDNA fragment was identical to
reading frame YER043c on chromosome V that was previ-
ously designated SAH1, based on its homology to Leishmania
donovani SAH [24].
Multiple sequence alignments of the Sah1 proteins from
diﬀerent organisms including Archaea (Sulfolobus solfataricus),
Eubacteria (Rhodobacter capsulatus), yeast (S. cerevisiae), slime
mold (Dictyostelium discoideum) and higher eukaryotes
Fig. 2. Multiple sequence alignment of Sah1p from diﬀerent organisms, including yeast Saccharomyces cerevisiae – S .cer; Eubacteria Rhodobacter
capsulatus – R. cap; slime mold Dictyostelium discoideum – D. dis; plant Petroselenium crispum – P. cri; human Homo sapiens – H. sap; and Archaea
Sulfolobus solfataricus – S. sol (10–15).
Fig. 3. Sah1p is an essential enzyme. Yeast tetrad analysis of
(A) diploid disruptant strain MSH-100, heterozygous for the sah1
chromosomal locus (SAH1/sah1::URA3), and (B) diploid disruptant
strain MSH-120 (SAH1/sah1::URA3), harboring the cognate SAH1
gene on plasmid pMA91.
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[25–30] showed overall sequence homology of about 80%
(Fig. 2). Yeast and human SAH are about 70% identical; thus,
Sah1p is among the 90 most highly conserved yeast proteins,
including actin (90% identity), ubiquitin (90%), histones
(70–90%), ribosomal (70%) and heat shock proteins (70%) [31].
3.2. Sah1p is an essential enzyme in yeast
To verify the identity of the cloned gene, gene disruptions by
insertion of URA3 or LEU2 markers into the chromosomal
SAH1 locus were performed. The diploid wild-type strain
W303D was transformed with linearized SAH1DURA3 and
SAH1DLEU2 fragments of plasmids p18:2DURA3 and
p18:2DLEU2, replacing the endogenous SAH1 locus, and re-
sulting in uracil and leucine prototrophy, respectively. Dis-
ruption was conﬁrmed by PCR using SAH1 and marker gene
speciﬁc primers (data not shown).
Sah1p speciﬁc activity of the diploid disruptant strains het-
erozygous for the SAH1 chromosomal locus was reduced by
40–50%, compared to the diploid wild-type control, reﬂecting
the reduced gene copy number in this strain (data not shown).
Upon dissection of diploid disruptant strain MSH-100 het-
erozygous for the sah1 locus on YPD plates, only two spores
which were uracil auxotrophs germinated and led to the for-
mation of colonies (Fig. 3A). Spores containing the disrupted
sah1 locus either did not germinate or led to the formation of
microcolonies of 10–100 cells, which ceased in their further
growth. Neither supplementation with all amino acids (in-
cluding 10 mM cysteine) nor homocysteine supplementationrestored growth of haploid sah1::URA3 disruptant strains. In
order to prove that the lethal phenotype resulted indeed from
SAH1 disruption, the cognate plasmid harboring the entire
wild-type SAH1 gene under control of the constitutive PGK
promoter was transformed into the heterozygous diploid dis-
ruption strain MSH-100, prior to tetrad dissection. Appear-
ance of four viable colonies on the dissection plate
demonstrated that the cognate clone complemented the lethal
sah1 mutant phenotype (Fig. 3B). Continuous growth of these
transformants under non-selective conditions (YPD medium)
did not result in loss of the episomal plasmid, indicating that
SAH1 is not only essential for germination, but also for veg-
etative growth.
Fig. 5. Regulation of Sah1p at the levels of gene expression and en-
zyme activity in wild-type strain W303D grown to OD600¼ 1 in the
absence or presence of lipid precursors, inositol and choline, as indi-
cated. PMA1 mRNA was used as an internal standard (3.5 kb, upper
band). Enzyme activity was measured as described in Section 2. Assays
were performed in duplicate.
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expression of SAH1, the gene was placed under the control of
the regulatable GAL1 promoter and transformed into strain
YSH-100, heterozygous for the chromosomal SAH1 locus
(SAH1/sah1::LEU2). After sporulation, haploid strains with a
deleted chromosomal allele of the SAH1 gene and harboring
the complementing plasmid were selected on galactose plates
(strain YSH-121; sah1::LEU2 pGAL1-SAH1). After shift to
glucose media, resulting in repression of GAL1-driven SAH1
expression, strain YSH-121 grew very poorly and reached only
40% of the growth rate compared to cultivation in galactose-
containing media. In the presence of 1 mM methionine in the
growth medium, a large fraction of cells arrested in a peculiar
terminal phenotype, characterized by altered morphology and
multiple buds (Fig. 4). Staining with the DNA-speciﬁc ﬂuo-
rescence dye, DAPI (40; 60 diamidino-2-phenylindole), indi-
cated that nuclear division in these cells was completed,
suggesting that SAH1 depletion resulted in a block in a late
stage of cytokinesis (data not shown).
3.3. SAH1 is regulated at the transcriptional level in
coordination with phospholipid biosynthetic genes
Sequence analysis of the 50 region of SAH1 revealed that at
position –242 a 50-GCACGTGAT-30 sequence matching the
consensus UASINO sequence, 5
0-GCATGTGAA-30, is present.
UASINO mediates regulation of phospholipid biosynthetic
genes in response to lipid precursors, inositol and choline [8].
In order to analyse the potential coregulation with genes in-
volved in phospholipid biosynthesis, we have measured SAH1
steady state mRNA levels in wild-type cells grown in the
presence or absence of inositol (80 lM) and/or choline (1 mM).
As shown in Fig. 5, SAH1 was repressed in the presence of
inositol by 20%, and was further repressed upon addition of
choline to inositol-containing medium by 86%, compared to
unsupplemented conditions. Choline alone had an intermedi-
ate repressing eﬀect on SAH1 expression. The repression of
SAH1 in response to inositol and choline availability was in
the range of other genes involved in phospholipid synthesis
[32]. Thus, Sah1p is regulated at the transcriptional level in
coordination with genes involved in phospholipid metabolism,
most likely through the consensus UASINO sequence. This
diﬀerential regulation by lipid precursor supplementation is
also reﬂected at the level of enzyme activity (Fig. 5). Interest-Fig. 4. Depletion of Sah1p in the sah1 disruption strain YSH-120
(SAH1/sah1::LEU2), expressing SAH1 under control of the GAL1
promoter, results in a multiple budding phenotype in the presence of
glucose and 1 mM methionine.ingly, SAH1 was not picked up in a recent micro array study to
identify genes transcriptionally controlled by inositol, and by
Ino2/Ino4 and Opi1 regulatory factors [33]. The lack of de-
tection of SAH1 cDNA on gene arrays may be due to the low
expression level and/or diﬀerent cultivation conditions prior to
RNA extraction.
The UASINO sequence of the SAH1 gene (5
0-GCACGTGA-
30) overlaps with the consensus UASMET sequence, 50-
TCACGTGA-30 that mediates regulation of genes whose
products are involved in sulfur assimilation in response to
methionine/AdoMet availability [34]. Thus, we investigated
whether methionine supplementation also aﬀected SAH1
transcription. Supplementation of the growth medium with 0.1
or 1 mM methionine in the absence of lipid precursors, inositol
and choline, did not change SAH1 steady state mRNA levels
(data not shown). However, Sah1p activity levels were reduced
by 25% or 60% upon growth in the presence of 0.1 or 1 mM
methionine, respectively, compared to unsupplemented con-
ditions. These data suggest that regulation of Sah1p by me-
thionine occurs at the post-transcriptional level.3.4. Modulation of SAH1 expression aﬀects lipid composition
Upon conditions of SAH1 repression in the absence of
methionine, we observed that lipid droplets accumulated in
strain YSH-121 already during logarithmic growth, a feature
normally observed in later stages of growth in wild-type cells.
Cell volume increased and frequent cell lysis occurred upon
extended cultivation on glucose. This observation prompted us
to analyze phospholipid, triacylglycerol, sterol and steryl ester
content under conditions of Sah1p depletion in various stages
of growth. Strain YSH-121 was cultivated with glucose as
carbon source and collected at early-log, mid-log and late-log
phases of growth. Under these conditions, biosynthesis of all
lipid classes was signiﬁcantly altered. Depletion of SAH1 in the
presence of glucose resulted in signiﬁcantly reduced content of
total phospholipids in an early phase of growth (OD600¼ 1),
whereas total sterols and triacylglycerol levels accumulated up
to 2- and 5-fold, in comparison to wild type, during growth
Table 1
Deregulation of lipid synthesis in response to modulation of SAH1 expressiona
Strain/conditions OD600 Phospholipids,
·103 lg
phosphorus/lg protein
Sterols, lg/lg
phosphorus
Steryl esters,
lg/lg phosphorus
Triacylglycerols,
lg/lg phosphorus
Wild type W303, glucose 1 38.5 ± 0.3 3.1 ± 0.3 1.3 ± 0.7 1.7 ± 0.2
5 46.3 ± 1.9 2.6 ± 0.5 1.3 ± 0.2 4.5 ± 0.2
10 48.6 ± 2.6 2.7 ± 0.3 6.7 ± 0.3 9.7 ± 0.9
YSH-121, glucose 1 10.9 ± 1.2 3.1 ± 0.1 1.4 ± 0.6 7.9 ± 0.2
5 45.5 ± 5.1 9.8 ± 0.9 3.9 ± 0.2 10.5 ± 2.3
10 38.2 ± 0.2 4.9 ± 0.1 6.1 ± 0.4 18.6 ± 0.1
a The data represent two biological and two technical replicates shown as mean values ± S.E.
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upon depletion of Sah1p is in line with the observed accu-
mulation of lipid droplets.4. Discussion
AdoMet-dependent methyltransferases catalyze the bulk of
methylation reactions in the cell. Regulation of the pool of
AdoHcy, a strong product inhibitor of all AdoMet-dependent
methyltransferases, is, therefore, of imminent importance [1,2].
In most organisms, AdoHcy is catabolized by Sah1p, which
thus plays a pivotal role in regulating the methylation potential
in the cell. Interference with Sah1p activity potentially aﬀects
methylation of diﬀerent molecule classes, including phospho-
lipids, sterols, DNA, RNA and proteins, and is associated with
high cytotoxicity [1,2].
Sah1p has maintained its primary sequence – and presum-
ably its function – throughout evolution. The bacterial R.
capsulatus SAH (ashY gene product) shows one of the highest
levels of conservation that has been observed between human
and bacterial enzymes [26]. Yeast and human SAH are about
70% identical, and the yeast ortholog is thus among the 90
most highly conserved yeast proteins [31]. Consistent with its
important metabolic function, we found that Sah1p is an es-
sential enzyme in yeast, which is in line with previous ﬁndings
resulting from a genome wide functional approach [35].
However, conﬂicting results exist on the viability of sah1 dis-
ruptant strains derived from a study making use of Ty1
transposon insertions in genes of chromosome V of S. cerevi-
siae [36]. Also, in a recent study, sah1 insertion mutants could
be rescued by addition of cysteine or homocysteine to the
growth media [37]: the sah1 mutant was obtained by insertion
of the URA3 selection marker between nucleotides +1100 of
the reading frame, and 197 base pairs downstream of the
SAH1 stop codon, which only eliminated the C-terminal 83
amino acids. Since the conserved regions of the enzyme are not
included in this area, Sah1p function presumably was not
completely eliminated in this mutant, resulting in a rather
leaky phenotype that could be rescued by amino acid supple-
mentation. However, use of this mutant in comparison to cells
(conditionally) depleted of SAH may prove useful to dissect
molecular mechanisms associated with cytotoxicity of SAH
directed inhibitors, and metabolic consequences due to a lack
of sulfur recycling. Consistent with an essential function of
Sah1p in yeast, disruption of the Ahcy locus in the mouse re-
sults in early embryonic lethality [38]. Interestingly, disruption
of the ahcY gene coding for SAH in the gram-negative bac-terium R. capsulatus has no eﬀect on viability [26] if methio-
nine or homocysteine is provided, and numerous organisms
lack SAH orthologs altogether. However, the existence in these
cell types of an alternative system to degrade AdoHcy, i.e., by
S-adenosylhomocysteine nucleosidase and S-ribosylhomocys-
teine hydrolase, underscores the physiological importance of
AdoHcy removal from the cellular milieu.
Very recently, a temperature sensitive mutant allele of
SAH1, sah1-1, was identiﬁed as a suppressor of the Ca2þ
sensitive phenotype of zds1 null mutants [39]: Zds1p is in-
volved in chromatin silencing, aging and establishment of cell
polarity, and the mutant is characterized by a growth defect,
G2 cell cycle delay and polarized bud growth. Accumulation of
both AdoHcy and AdoMet in the sah1-1 mutant was shown to
result in repression of SWE1 and CLN2 gene expression,
which are both involved in cell cycle control and upregulated
in the zds1 mutant. A similar, albeit less pronounced sup-
pressing eﬀect on the Ca2þ-sensitivity of zds1 mutants was
achieved by supplementation of cells with AdoMet or Ado-
Hcy. Although the mechanisms by which these compounds
downregulate SWE1 and CLN2 expression are not known,
these data further underscore the importance of maintaining
the AdoMet/AdoHcy ratio and, consequently, the cellular
methylation potential, by Sah1p.
In yeast, most genes encoding enzymes of phospholipid
biosynthesis are subject to regulation at the level of tran-
scription in response to the availability of lipid precursors,
inositol and choline. This transcriptional control is mediated
through one or more copies of UASINO in the promoter re-
gions of these genes, and is, in particular, dependent on the
continuous synthesis of PtdCho [8]. The ﬁnal three steps in
PtdCho biosynthesis are catalyzed by AdoMet-dependent
methyltransferases, Cho2p and Opi3p and may, thus, be sen-
sitive to the AdoHcy/AdoMet ratio and Sah1p activity level in
the cell. Identiﬁcation of an inositol/choline response element
(ICRE, UASINO) in the promoter region of the SAH1 gene and
its regulation in accordance with genes involved in phospho-
lipid synthesis suggests a coordination of Sah1p activity level
in the cell with ongoing phospholipid synthesis. Indeed, pre-
liminary experiments suggest that overexpression of SAH1 in
partially methylation-deﬁcient yeast strains (cho2 or opi3 mu-
tants, defective in phosphatidylethanolamine N-methyltrans-
ferase, and phospholipid N-methyltransferase activities,
respectively) stimulated residual methylation and suppressed
to some extent phenotypes associated with these mutations
(Tehlivets and Kohlwein, unpublished). Interestingly, in con-
trast to other genes involved in phospholipid synthesis, we
found that SAH1 expression was also signiﬁcantly repressed
506 O. Tehlivets et al. / FEBS Letters 577 (2004) 501–506by choline. Incorporation of choline into PtdCho via the
Kennedy-pathway provides an alternative route to the de novo
pathway, which requires AdoMet-dependent methylation. The
observed downregulation of SAH1 expression by choline may
reﬂect a reduced requirement for de novo PtdCho synthesis
under conditions of choline supplementation.
The repression of Sah1p activity by methionine indicates
additional coordinative regulation with enzymes involved in
sulfur assimilation and AdoMet formation [34]. Thus, Sah1p
potentially represents a convergence point of phospholipid and
methionine speciﬁc regulation. The impact of Sah1p controlled
methylation and phospholipid synthesis is also evident from
data based on conditional SAH1 expression. Not only PtdCho
synthesis was found to be drastically aﬀected upon Sah1p de-
pletion. Both sterol and steryl esters accumulated signiﬁcantly
under these conditions, also reﬂecting interference of altered
methylation potential with sterol formation, presumably at the
level of D24-sterol-C-methyltransferase (Erg6p). In fact, studies
have demonstrated that structural analogs of AdoHcy inhib-
ited Erg6p activity in vitro [40]. However, most signiﬁcantly,
depletion of SAH1 led to an accumulation of triacylglycerols
in the cell. These observations directly link activity of the en-
zyme to alterations in lipid homeostasis. Sah1p catalysis not
only functions both in the direction of AdoHcy hydrolysis, but
also in the reverse reaction, utilizing homocysteine and aden-
osine to form AdoHcy. It is tempting to speculate that one
potential mechanism of homocysteine as a risk factor for in-
ducing lipid alterations in humans is by altering the methyla-
tion potential of the cell through elevated Sah1p-dependent
AdoHcy formation.
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